Fast Market Research announces the availability of the new TechNavio report, "Global Antipsychotic Drugs Market 2017-2021", on their comprehensive research portal

Boston, MA -- (SBWire) -- 06/22/2017 --Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.

Technavio's analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Get More Details on this Report and a Full Table of Contents at Global Antipsychotic Drugs Market 2017-2021

Technavio's report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-Eli Lilly
-GlaxoSmithKline
-Johnson & Johnson

Other prominent vendors

-Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
-Alkermes
-Bristol-Myers Squibb

Market driver

-Increasing expenditure on prescription drugs
-For a full, detailed list, view our report

Market challenge

-Lack of standard diagnostic methods
-For a full, detailed list, view our report

Market trend

-Rising public interest toward mental health
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Actavis Generics (a subsidiary of Teva Pharmaceutical Industries), Alkermes, Bristol-Myers Squibb

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Solid Tumors Drugs Market 2016-2020
-Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
-The Future of Generic Drugs and Strategies for Commercial Success
-Global Pain Management Drugs Market 2016-2020
-Global Antifungal Drugs Market 2017-2021